<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Proteomics International Laboratories Ltd. — News on 6ix</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd</link>
<description>Latest news and press releases for Proteomics International Laboratories Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 03:20:09 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/proteomics-intl-labs-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683668ab78dffbe2df15ed06.webp</url>
<title>Proteomics International Laboratories Ltd.</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd</link>
</image>
<item>
<title>Proteomics Strategic Plan</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/proteomics-strategic-plan</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/proteomics-strategic-plan</guid>
<pubDate>Tue, 28 Apr 2026 03:20:09 GMT</pubDate>
<description>Proteomics Strategic Plan</description>
</item>
<item>
<title>Restructure, Executive Appointment and Board Update</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/restructure-executive-appointment-and-board-update</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/restructure-executive-appointment-and-board-update</guid>
<pubDate>Fri, 17 Apr 2026 03:42:05 GMT</pubDate>
<description>Restructure, Executive Appointment and Board Update</description>
</item>
<item>
<title>Appendix 4D and Interim Financial Report</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/appendix-4d-and-interim-financial-report-53</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/appendix-4d-and-interim-financial-report-53</guid>
<pubDate>Wed, 25 Feb 2026 03:04:27 GMT</pubDate>
<description>Appendix 4D and Interim Financial Report</description>
</item>
<item>
<title>Quarterly Activities/Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-79</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-79</guid>
<pubDate>Fri, 30 Jan 2026 02:46:08 GMT</pubDate>
<description>Quarterly Activities/Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>Canadian patent secured for PromarkerEso test for EAC</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/canadian-patent-secured-for-promarkereso-test-for-eac</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/canadian-patent-secured-for-promarkereso-test-for-eac</guid>
<pubDate>Fri, 16 Jan 2026 02:43:12 GMT</pubDate>
<description>Canadian patent secured for PromarkerEso test for EAC</description>
</item>
<item>
<title>Appointment of CEO and Managing Director</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/appointment-of-ceo-and-managing-director-5</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/appointment-of-ceo-and-managing-director-5</guid>
<pubDate>Wed, 14 Jan 2026 03:05:08 GMT</pubDate>
<description>Appointment of CEO and Managing Director</description>
</item>
<item>
<title>Proteomics US lab CAP accredited - extends precision Dx lab</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/proteomics-us-lab-cap-accredited-extends-precision-dx-lab</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/proteomics-us-lab-cap-accredited-extends-precision-dx-lab</guid>
<pubDate>Wed, 24 Dec 2025 04:36:03 GMT</pubDate>
<description>Proteomics US lab CAP accredited - extends precision Dx lab</description>
</item>
<item>
<title>US patent secured for PromarkerEso diagnostic test for EAC</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/us-patent-secured-for-promarkereso-diagnostic-test-for-eac</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/us-patent-secured-for-promarkereso-diagnostic-test-for-eac</guid>
<pubDate>Wed, 17 Dec 2025 02:54:14 GMT</pubDate>
<description>US patent secured for PromarkerEso diagnostic test for EAC</description>
</item>
<item>
<title>PromarkerD predicts risk of DKD in Aboriginal Australians</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/promarkerd-predicts-risk-of-dkd-in-aboriginal-australians</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/promarkerd-predicts-risk-of-dkd-in-aboriginal-australians</guid>
<pubDate>Mon, 15 Dec 2025 02:42:06 GMT</pubDate>
<description>PromarkerD predicts risk of DKD in Aboriginal Australians</description>
</item>
<item>
<title>Response to ASX Price Query</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/response-to-asx-price-query-187</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/response-to-asx-price-query-187</guid>
<pubDate>Tue, 02 Dec 2025 10:13:04 GMT</pubDate>
<description>Response to ASX Price Query</description>
</item>
<item>
<title>US Medicare sets reimbursement price for PromarkerD DKD test</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/us-medicare-sets-reimbursement-price-for-promarkerd-dkd-test</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/us-medicare-sets-reimbursement-price-for-promarkerd-dkd-test</guid>
<pubDate>Wed, 26 Nov 2025 04:19:11 GMT</pubDate>
<description>US Medicare sets reimbursement price for PromarkerD DKD test</description>
</item>
<item>
<title>OxiDx test correlates with superior racehorse performance</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/oxidx-test-correlates-with-superior-racehorse-performance</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/oxidx-test-correlates-with-superior-racehorse-performance</guid>
<pubDate>Mon, 24 Nov 2025 02:58:17 GMT</pubDate>
<description>OxiDx test correlates with superior racehorse performance</description>
</item>
<item>
<title>Proteomics International receives $2.2m in R&D tax incentive</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/proteomics-international-receives-dollar22m-in-randd-tax-incentive</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/proteomics-international-receives-dollar22m-in-randd-tax-incentive</guid>
<pubDate>Wed, 12 Nov 2025 03:25:11 GMT</pubDate>
<description>Proteomics International receives $2.2m in R&D tax incentive</description>
</item>
<item>
<title>PromarkerEndo test for endometriosis receives $0.5m grant</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/promarkerendo-test-for-endometriosis-receives-dollar05m-grant</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/promarkerendo-test-for-endometriosis-receives-dollar05m-grant</guid>
<pubDate>Thu, 06 Nov 2025 08:12:03 GMT</pubDate>
<description>PromarkerEndo test for endometriosis receives $0.5m grant</description>
</item>
<item>
<title>Collaboration expanded to advance Endometriosis blood test</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/collaboration-expanded-to-advance-endometriosis-blood-test</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/collaboration-expanded-to-advance-endometriosis-blood-test</guid>
<pubDate>Wed, 15 Oct 2025 01:54:27 GMT</pubDate>
<description>Collaboration expanded to advance Endometriosis blood test</description>
</item>
<item>
<title>Proteomics granted certification for Diagnostics Laboratory</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/proteomics-granted-certification-for-diagnostics-laboratory</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/proteomics-granted-certification-for-diagnostics-laboratory</guid>
<pubDate>Thu, 18 Sep 2025 02:47:27 GMT</pubDate>
<description>Proteomics granted certification for Diagnostics Laboratory</description>
</item>
<item>
<title>Board and Management Transition</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/board-and-management-transition-2</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/board-and-management-transition-2</guid>
<pubDate>Tue, 09 Sep 2025 03:14:13 GMT</pubDate>
<description>Board and Management Transition</description>
</item>
<item>
<title>PromarkerEso precisely detects early stage esophageal cancer</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/promarkereso-precisely-detects-early-stage-esophageal-cancer</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/promarkereso-precisely-detects-early-stage-esophageal-cancer</guid>
<pubDate>Mon, 08 Sep 2025 02:57:10 GMT</pubDate>
<description>PromarkerEso precisely detects early stage esophageal cancer</description>
</item>
<item>
<title>Preliminary Final Report</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/preliminary-final-report-193</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/preliminary-final-report-193</guid>
<pubDate>Wed, 27 Aug 2025 03:25:21 GMT</pubDate>
<description>Preliminary Final Report</description>
</item>
<item>
<title>OxiDx test detects muscle damage in thoroughbred racehorses</title>
<link>https://6ix.com/company/proteomics-intl-labs-ltd/news/oxidx-test-detects-muscle-damage-in-thoroughbred-racehorses</link>
<guid isPermaLink="true">https://6ix.com/company/proteomics-intl-labs-ltd/news/oxidx-test-detects-muscle-damage-in-thoroughbred-racehorses</guid>
<pubDate>Mon, 14 Jul 2025 02:40:13 GMT</pubDate>
<description>OxiDx test detects muscle damage in thoroughbred racehorses</description>
</item>
</channel>
</rss>